These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 28658304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
    Kennel SJ, Mirzadeh S, Eckelman WC, Waldmann TA, Garmestani K, Yordanov AT, Stabin MG, Brechbiel MW.
    Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T, Andersson H, Divgi CR, Hultborn R, Jensen H, Lindegren S, Palm S, Jacobsson L.
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [Abstract] [Full Text] [Related]

  • 7. Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model.
    Li HK, Morokoshi Y, Kodaira S, Kusumoto T, Minegishi K, Kanda H, Nagatsu K, Hasegawa S.
    J Nucl Med; 2021 Oct; 62(10):1468-1474. PubMed ID: 33547212
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.
    Zalutsky MR, Bigner DD.
    Acta Oncol; 1996 Oct; 35(3):373-9. PubMed ID: 8679269
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR, Pozzi OR.
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [Abstract] [Full Text] [Related]

  • 10. In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fraction.
    Akabani G, Carlin S, Welsh P, Zalutsky MR.
    Nucl Med Biol; 2006 Apr; 33(3):333-47. PubMed ID: 16631082
    [Abstract] [Full Text] [Related]

  • 11. Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma model.
    Eriksson SE, Elgström E, Bäck T, Ohlsson T, Jensen H, Nilsson R, Lindegren S, Tennvall J.
    Cancer Biother Radiopharm; 2014 Aug; 29(6):238-46. PubMed ID: 24971673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.
    Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Johansson BR, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2006 Aug; 47(8):1342-50. PubMed ID: 16883015
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
    Andersson H, Palm S, Lindegren S, Bäck T, Jacobsson L, Leser G, Horvath G.
    Anticancer Res; 2001 Aug; 21(1A):409-12. PubMed ID: 11299770
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy.
    Humm JL.
    Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1767-73. PubMed ID: 3667382
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.